1. The Novelty of miRNAs as a Clinical Biomarker for the Management of PCOS
   Rana Alhamdan et al, 2022, Polycystic Ovary Syndrome - Functional Investigation and Clinical Application CrossRef
2. The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review
   Salvatore Giovanni Vitale et al, 2022, Biomedicines CrossRef
3. Integrated Analysis of Hub Genes and miRNAs in Dilated Cardiomyopathy
   Kai Huang et al, 2020, BioMed Research International CrossRef
4. Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks
   Roozbeh Heidarzadehpilehrood et al, 2023, Iranian Journal of Pharmaceutical Research CrossRef
5. Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome
   Yuanqi Li et al, 2021, Computational and Mathematical Methods in Medicine CrossRef
6. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis
   Zhi Zeng et al, 2020, BioMed Research International CrossRef
7. microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndrome
   Mona Tamaddon et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
8. MiR-383-5p promotes apoptosis of ovarian granulosa cells by targeting CIRP through the PI3K/AKT signaling pathway
   Yunying Li et al, 2022, Archives of Gynecology and Obstetrics CrossRef
9. Circ_FURIN knockdown assuages Testosterone-induced human ovarian granulosa-like tumor cell disorders by sponging miR-423-5p to reduce MTM1 expression in polycystic ovary syndrome
   Xia Xu et al, 2022, Reproductive Biology and Endocrinology CrossRef